Muneer Ali, MD

Dr. Ali is a clinical psychiatrist who likes to take a whole person, therapeutic approach and understand his patients in the context of their life experiences, and then work with them to figure out where they want to go and how to get there. Dr. Ali takes a particular interest in ADHD, anxiety disorders, and substance use disorders. He completed his training in Psychiatry at the State University of New York, completed a Fellowship in Child and Adolescent Psychiatry, and served as Chief Fellow in his final year. Dr. Ali is double Board-certified in Adult and Child/Adolescent Psychiatry through the American Board of Psychiatry and Neurology.  He works with Amen Clinics in the Atlanta metro area.

Lisa Brown, PhD

Lisa Brown earned her PhD in Biomedical Sciences at Albert Einstein in 2015, studying microbiology and infectious disease with Arturo Casadevall, MD, PhD. She then went on to a career in medical affairs by joining Assurex Health/Myriad Neuroscience as a Medical Science Liaison. At Myriad, Lisa managed an international team of MSLs until 2020 when she moved on to Tempus Labs as their first NeuroPsych MSL. Lisa has published multiple book chapters and over a dozen peer-reviewed publications. Lisa is passionate about using science and technology to improve mental healthcare and also has a special interest in psychopharmacomicrobiomics.

Boadie Dunlop, MD, MSCR

Boadie Dunlop, MD, MSCR, has served as the Director of the Mood and Anxiety Disorders Program (MAP) at Emory University since 2006. He graduated from Mayo Medical School in 1997 and completed his Residency in Psychiatry at Emory in 2001. His clinical research is focused on the neurobiology, psychopharmacology and treatment of major depression, bipolar disorder, and anxiety disorders. Through the MAP research program he conducts both industry-sponsored trials of investigational medications and biologically-oriented studies sponsored by federal and other non-profit organizations. These projects frequently involve collaboration with pre-clinical and clinical researchers in neurology, radiology, genetics and psychology. Dr. Dunlop’s additional areas of interest include decision-making in psychiatric disorders and the ethics of clinical research.

James Greenblatt, MD

A pioneer in the field of integrative medicine, James M. Greenblatt, MD, has treated patients since 1988. After receiving his medical degree and completing his psychiatry residency at George Washington University, Dr. Greenblatt completed a fellowship in child and adolescent psychiatry at Johns Hopkins Medical School. He has served as the Chief Medical Officer at Walden Behavioral Care in Waltham, MA for nearly 20 years, and is an Assistant Clinical Professor of Psychiatry at Tufts University School of Medicine and Dartmouth College Geisel School of Medicine. Dr. Greenblatt has lectured internationally on the scientific evidence for nutritional interventions in psychiatry and mental illness. He is also the founder of Psychiatry Redefined, and author of eight books, including Finally Focused: The Breakthrough Natural Treatment Plan for ADHD, and Nutritional Lithium: A Cinderella Story.

Kelly Heim, PhD

Kelly Heim, Ph.D. is a pharmacologist specializing in natural products. He is Senior Scientific Director, Pharmacology & Genomics for Pure Encapsulations and Douglas Laboratories, where he advises professional medical education and genomics platform development. Dr. Heim is a graduate of Geisel School of Medicine at Dartmouth College and has published several invited reviews and book chapters on polyphenol chemistry, mechanisms and applications. He offers complimentary learning resources on the basic and clinical pharmacology of natural products via his website, IntegrativePharmacology.com.